Cardiology · 2025
A Resident-Led Quality Improvement Initiative to Accelerate Medical Therapy Implementation in Acute Heart Failure: ACCELERATE-HF.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Alexander Bryce, Jackson Robyn, Builes Angela, Sheerah Shahad, Nikel Taylor, Sharma Arjun Narain, Scott Laura, Lam Jeffrey, McLean Drew, Wong Sheung Wing Sherwin, Wood Rebecca, Almufleh Aws
Аннотация
INTRODUCTION: Guideline-directed medical therapy (GDMT) optimization and effective de-congestion are known to improve outcomes in admitted heart failure (HF) patients, yet their implementation is suboptimal. Using an HF decision aid and point-of-care ultrasound (POCUS) at admission, this resident-led quality improvement (QI) initiative aimed to improve GDMT use and reduce HF readmissions.
METHODS: This prospective, single-center QI initiative compared resident-performed POCUS and HF decision-aid use (the QI arm) with routine hospital care in admitted HF patients. Assignment to the QI arm was based on the availability of residents trained to perform POCUS on admission.
PRIMARY OUTCOME: 30-day hospital readmission; secondary outcomes: GDMT utilization using a standard score, adverse outcome occurrence, and 30-day mortality.
RESULTS: The study was terminated early due to funding constraints. We enrolled 103 (42 in the QI arm) out of the planned 254 patients. At discharge, the QI arm had a trend towards improvement in GDMT scores (+21 ± 23% vs. +12 ± 24% in controls, p = 0.106). In particular, a numerically higher proportion of patients in the QI arm were discharged on renin-angiotensin-aldosterone blockers (70.4% vs. 51.4% of controls, p = 0.126). Adverse effect occurrence and 30-day outcomes (readmissions and mortality) were not significantly different between groups. Significantly more people in the QI arm had a transthoracic echocardiogram in the hospital (26 [65.0%] vs. control: 21 [38.9%], p = 0.012).
CONCLUSION: This study showed that a resident-led QI initiative was feasible and resulted in modest improvement in GDMT use and echocardiography utilization, but without effectively altering 30-day outcomes.
METHODS: This prospective, single-center QI initiative compared resident-performed POCUS and HF decision-aid use (the QI arm) with routine hospital care in admitted HF patients. Assignment to the QI arm was based on the availability of residents trained to perform POCUS on admission.
PRIMARY OUTCOME: 30-day hospital readmission; secondary outcomes: GDMT utilization using a standard score, adverse outcome occurrence, and 30-day mortality.
RESULTS: The study was terminated early due to funding constraints. We enrolled 103 (42 in the QI arm) out of the planned 254 patients. At discharge, the QI arm had a trend towards improvement in GDMT scores (+21 ± 23% vs. +12 ± 24% in controls, p = 0.106). In particular, a numerically higher proportion of patients in the QI arm were discharged on renin-angiotensin-aldosterone blockers (70.4% vs. 51.4% of controls, p = 0.126). Adverse effect occurrence and 30-day outcomes (readmissions and mortality) were not significantly different between groups. Significantly more people in the QI arm had a transthoracic echocardiogram in the hospital (26 [65.0%] vs. control: 21 [38.9%], p = 0.012).
CONCLUSION: This study showed that a resident-led QI initiative was feasible and resulted in modest improvement in GDMT use and echocardiography utilization, but without effectively altering 30-day outcomes.